Search bioRxiv⌕ Search

bioRxiv · 10.1101/2023.12.18.572208

eCV: Enhanced coefficient of variation and IDR extensions for reproducibility 1 assessment of high-throughput experiments with multiple replicates.

Abstract

MotivationReproducibility assessment is essential in extracting reliable scientific insights from highthroughput experiments. Inconsistency between technical replicates poses a challenge, particularly clear in next generation sequencing technologies based on immunoprecipitations, where the assessment of reproducibility in peak identification is a critical analytical step. While the Irreproducibility Discovery Rate (IDR) method has been instrumental in assessing reproducibility, its standard implementation is constrained to handling only two replicates. In the current era of steadily growing sample sizes, eased by multiplexing and reduced sequencing costs, highly performing methods that handle any number of replicates are desirable. ResultsWe introduce three novel methods for reproducibility assessment in high-throughput data that handle an arbitrary number of replicates. The first, general IDR (gIDR), extends the standard IDR by adapting its Expectation-Maximization (EM) algorithm to handle distributions of any dimensions dictated by the number of replicates. The second, meta-IDR (mIDR), employs a meta-analysis approach, calculating local IDR scores for all pairs of replicates and combining them using standard probability rules. The third method introduces an "enhanced" Coefficient of Variation (eCV), ranking features based on intensity and variability, using a parametric bootstrap approach to obtain an index analogous to local IDR. Comparative analysis with traditional IDR in simulated and experimental data reveals the heightened performance of the proposed multivariate alternatives under varying scenarios, thereby addressing the critical challenge of reproducibility assessment in contemporary high-throughput experiments. Availability and implementationThe described methods are implemented as an R package: https://github.com/eclipsebio/eCV Contactinfo@eclipsebio.com

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Gonzalez-Reymundez, A. M., Shen, K., Doyle, W., Peng, S., Hutt, K., Bruns, S.. 2023-12-19. eCV: Enhanced coefficient of variation and IDR extensions for reproducibility 1 assessment of high-throughput experiments with multiple replicates.. https://doi.org/10.1101/2023.12.18.572208

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Targeted finetuning enables co-folding models to learn ligand-induced protein conformational states

Advances in protein structure prediction have enabled all-atom protein-ligand co-folding models that predict bound conformations directly from sequence and small-molecule structure. However, these models often fail to generalize to novel binding sites or alternative protein conformational states, limiting their utility for chemical biology and drug discovery. Here we show this limitation reflects training data bias rather than architectural constraints and can be overcome through targeted finetuning. Using ten previously unseen X-ray structures of Werner (WRN) helicase from a drug discovery program, we finetune Boltz-1 to learn both an allosteric binding site and a large conformational change locking the enzyme in an inactive state, while preserving accuracy on the ATP-bound state. The finetuned model generalizes to different chemical series and transfers the conformational logic across RecQ-family helicases in a binding-site sequence-dependent manner. This approach provides a blueprint for adapting foundation models as new structural and mechanistic data emerge, enabling co-folding networks to capture ligand-induced conformational switches and binding poses absent from their training data but central to biological regulation and therapeutic intervention.

bioinformatics↗

Benchmarking single-cell foundation models for aging biology

Single cell foundation models (scFMs) provide representations of cellular states, but their utility across biological questions in aging research remains unclear. We established a benchmark of cellular representations for aging research, evaluating ten general-purpose scFMs, three aging-specific models and conventional methods across five biological questions using more than 2.5 million single cell transcriptomes. Using frozen pretrained representations, Geneformer performed best among scFMs for chronological age prediction and age pseudotime concordance, although 2,000 highly variable genes achieved higher mean performance. Several scFMs captured positive molecular age shifts across three disease contexts, consistent with reported aging-associated changes. SCimilarity performed well for rare cellular state identification across out-of-distribution datasets, exceeding aging specific models and conventional baselines. At the gene level, scGPT showed the highest recovery of reference TF target interactions, including aging-related regulatory hubs. Overall, scFMs supported diverse aging analyses, but performance depended on the biological question, highlighting their utility for rare cellular state identification and regulatory analysis.

bioinformatics↗

CryoMV: Structure-Prior-Guided Modeling and Real-Particle Validation of Continuous Conformational Transitions in Cryo-EM

Continuous protein conformations are essential for understanding fundamental biological processes and supporting drug discovery. Although cryo-EM can resolve individual states at high resolution, recovering continuous heterogeneity from 2D particle images remains challenging. High noise, motion blur, and limited structural priors make it difficult to accurately generate and validate high-resolution continuous conformations using raw particle data. Here, we introduce cryoMV, a framework that integrates structure-prior-guided modeling with real-particle validation for continuous conformational transitions. CryoMV uses reference density maps to establish structural anchors and motion priors, models candidate transition paths between selected conformations, and transfers the learned representation to raw 2D cryo-EM particle images. Each candidate conformation is subsequently evaluated using the estimated particle poses and contrast transfer functions. Supported conformations are reconstructed through raw particle back-projection and assessed using canonical half-maps and Fourier shell correlation. On EMPIAR-10516 and EMPIAR-10345, cryoMV achieves excellent performance in terms of robustness, verifiability, and reconstruction resolution. By incorporating structure-prior modeling and evidence from the raw particles, cryoMV offers an explicit mechanism for assessing whether generated conformations are supported by experimental data and provides a practical approach to reducing model-induced artifacts in continuous cryo-EM heterogeneity analysis.

bioinformatics↗